5.38 +0.00 (0.00%)
SNTA
| Trade SNTA now with |
|
Stock Details
Last Trade:5.38 Change:+0.00 (0.00%) Prev Close:5.38 Open: 144.85 Days Range:5.38 – 5.38 52 Week Range: 3.02 - 6.27 Volume:880 P/E: N/AEPS:-1.09
View AllRecent Alerts 02/09/12
Recent Alert on 02/06/12 at 4:12pm
Synta (SNTA) Completes Additional 1.05M Common Sale
Synta (SNTA) Completes Additional 1.05M Common Sale
Synta Pharmaceuticals Corp. (Nasdaq: SNTA) has completed the sale of 1,050,000 additional shares of its common stock pursuant to the full exercise of the over-allotment option granted to the underwriters of its previously announced public offering.... Read More
Recent Alert on 01/17/12 at 8:43am
Canaccord Genuity Reiterates a 'Buy' on Synta Pharma. (SNTA) Following Meeting with Management
Canaccord Genuity Reiterates a 'Buy' on Synta Pharma. (SNTA) Following Meeting with Management
Recent Alert on 01/12/12 at 9:07am
Synta (SNTA) Reports Publication of Yeast Screening Platform in Targeting Cancer Cell Metabolism
Synta (SNTA) Reports Publication of Yeast Screening Platform in Targeting Cancer Cell Metabolism
Recent Alert on 01/12/12 at 9:07am
Synta (SNTA) Reports Publication of Yeast Screening Platform in Targeting Cancer Cell Metabolism
Synta (SNTA) Reports Publication of Yeast Screening Platform in Targeting Cancer Cell Metabolism
View AllRecent Press Releases
Press Release on 02/08/12 at 7:59am
Synta to Host Fourth-Quarter and Year-End 2011 Conference Call on February 22, 2012
Synta to Host Fourth-Quarter and Year-End 2011 Conference Call on February 22, 2012
Press Release on 02/06/12 at 4:11pm
Synta Pharmaceuticals Sells Additional 1,050,000 Shares of Common Stock
Synta Pharmaceuticals Sells Additional 1,050,000 Shares of Common Stock
Press Release on 02/06/12 at 8:00am
Synta Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference
Synta Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference
View AllRecent SEC Filings
No Recent SEC Filings Available